Arul Chinnaiyan

Dr. Arul M. Chinnaiyan is a distinguished Professor of Pathology and Urology at the University of Michigan Medical School, where he serves as Director of the Michigan Center for Translational Pathology (MCTP) and an Investigator at the Howard Hughes Medical Institute. His work bridges translational cancer research and precision oncology, with a focus on prostate cancer biomarkers and gene fusion discovery. He has pioneered clinical tools like the MiPS test (combining TMPRSS2-ERG and PCA3) and the bioinformatics platform Oncomine.

• Education: M.D. and Ph.D. in Pathology
• Awards: Paul Marks Prize, NCI Outstanding Investigator Award, Sjöberg Prize (2022), AACR Academy Induction (2020)

His research spans genomics, epigenetics, and non-coding RNA biology, particularly in prostate cancer and solid tumors. His lab’s 2024–2025 publications highlight advances in FOXA1 mutations, CDK12/13 targeting, and neo-enhanceosome mechanisms. He mentors students like Yihan Liu and has trained notable alumni such as Benjamin Chandler and Jae Eun Choi.